parsatuzumab (RG7414) - Roche
Roche: Late-Stage Pipeline Event (Roche) - Oct 3, 2013 - Anticipated regulatory submission in EU for solid tumors in 2016 or after; Anticipated regulatory submission in US for solid tumors in 2016 or after 
Anticipated EU regulatory • Anticipated FDA event Oncology
http://www.roche.com/investors/ir_agenda/late-stage_pipeline_2013.htm
 
Oct 3, 2013
 
.
 
3b7d8be9-9943-49ea-b3b2-8d2943cf366b.jpg